Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (1321-1330 of 3,162) with videos related to

Pageof 317
Sort By:
Journal of Synchrotron Radiation|July 21, 2004
An ultrahigh-vacuum chamber for surface X-ray diffractionC L Nicklin, J S Taylor, N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 16, 2005
Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panelsJames E Ross, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|October 9, 1998
In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniaeR N Jones, D J Biedenbach, M A Croco, et al.
Archives of Family Medicine|May 1, 1997
Modifiable high-risk behaviors for cardiovascular disease among family physicians in the United States. A national SurveyK E LeBlanc, I C Scarinci, L L LeBlanc, et al.
Diagnostic Microbiology and Infectious Disease|March 15, 2006
Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004)Douglas J Biedenbach, Mark A Toleman, Timothy R Walsh, et al.
The Journal of Antimicrobial Chemotherapy|February 28, 2002
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepimePaul G Ambrose, Robert C Owens, Michael J Garvey, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infectionsThomas R Fritsche, Paul R Rhomberg, Helio S Sader, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 7, 2007
Association between psychomotor activity delirium subtypes and mortality among newly admitted post-acute facility patientsDan K Kiely, Richard N Jones, Margaret A Bergmann, et al.
Diagnostic Microbiology and Infectious Disease|March 23, 2007
Development of anidulafungin for disk diffusion susceptibility testing against Candida sppRonald N Jones, Jeffrey T Kirby, Shawn A Messer, et al.
International Journal of Antimicrobial Agents|November 23, 2006
Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004)Lalitagauri M Deshpande, Ronald N Jones, Thomas R Fritsche, et al.
Pageof 317

Showing results (1321-1330 of 3,162) with videos related to

Sort By:
Pageof 317
Journal of Synchrotron Radiation|July 21, 2004
An ultrahigh-vacuum chamber for surface X-ray diffractionC L Nicklin, J S Taylor, N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 16, 2005
Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panelsJames E Ross, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|October 9, 1998
In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniaeR N Jones, D J Biedenbach, M A Croco, et al.
Archives of Family Medicine|May 1, 1997
Modifiable high-risk behaviors for cardiovascular disease among family physicians in the United States. A national SurveyK E LeBlanc, I C Scarinci, L L LeBlanc, et al.
Diagnostic Microbiology and Infectious Disease|March 15, 2006
Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004)Douglas J Biedenbach, Mark A Toleman, Timothy R Walsh, et al.
The Journal of Antimicrobial Chemotherapy|February 28, 2002
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepimePaul G Ambrose, Robert C Owens, Michael J Garvey, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infectionsThomas R Fritsche, Paul R Rhomberg, Helio S Sader, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 7, 2007
Association between psychomotor activity delirium subtypes and mortality among newly admitted post-acute facility patientsDan K Kiely, Richard N Jones, Margaret A Bergmann, et al.
Diagnostic Microbiology and Infectious Disease|March 23, 2007
Development of anidulafungin for disk diffusion susceptibility testing against Candida sppRonald N Jones, Jeffrey T Kirby, Shawn A Messer, et al.
International Journal of Antimicrobial Agents|November 23, 2006
Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004)Lalitagauri M Deshpande, Ronald N Jones, Thomas R Fritsche, et al.
Pageof 317